Moleculin Biotech, Inc. (MBRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MBRX trades at $2.30 with a market cap of $11.15M and a P/E ratio of -0.08. MBRX moved +0.00% today. Year to date, MBRX is -40.00%; over the trailing twelve months it is -90.45%. Its 52-week range spans $1.79 to $91.25. Analyst consensus is strong buy with an average price target of $21.00. Rallies surfaces MBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Moleculin Biotech, Inc. (MBRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MBRX moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.30 |
| Market Cap | $11.15M |
| P/E Ratio | -0.08 |
| EPS | $-28.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $91.25 |
| 52-Week Low | $1.79 |
| Volume | 95.08K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-33.56M |
| Gross Margin | 0.00% |
3 analysts cover MBRX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.00.